相关实验视频
Updated: May 27, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
多发性骨髓瘤的新兴疗法:利用免疫检查点抑制剂改善结果
Anuja Anil Mandavkar1, Suraj Sai Nikhil Padakanti2, Srajan Gupta3
1Vilasrao Deshmukh Government Medical College, Latur, Maharashtra, India.
本综述探讨了多发性髓瘤的新型免疫疗法,包括免疫检查点抑制剂和CAR-T细胞疗法. 结合疗法有望改善患者的治疗结果,尽管瘤微环境存在挑战.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 多发性骨髓瘤是一种致命的血液癌症,由克隆性血细胞增殖驱动.
- 目前的治疗方法提供有限的治疗方法,突显了创新的治疗策略的需要.
研究的目的:
- 批判性地审查多发性骨髓瘤瘤的微环境.
- 总结新兴的免疫疗法和多发性髓瘤的组合治疗方法.
主要方法:
- 综述多发性髓瘤免疫治疗的最新进展.
- 对免疫检查点抑制剂 (ICI),组合疗法和CAR-T细胞疗法的分析.
主要成果:
- 针对PD-1/PD-L1和CTLA-4通路的免疫检查点抑制剂 (ICI) 增强了抗瘤免疫力.
- 组合疗法 (ICI与蛋白酶体抑制剂,免疫调节剂,单克隆抗体) 改善反应.
- 卡特-T细胞疗法,特别是与ICI结合,显示出对多发性骨髓瘤的有效性,减少复发.
结论:
- 尽管瘤微环境和免疫逃避带来了挑战,但组合疗法提供了新的希望.
- 对新的免疫检查点和向治疗的进一步研究对于个性化治疗至关重要.
- 强大的临床试验对于了解多发性骨髓瘤微环境和开发革命性的疗法至关重要.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
相关概念视频
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...